Palatin Technologies
PTN
#10723
Rank
S$17.56 M
Marketcap
S$9.87
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -S$7.96 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$12.88 Million. In 2025 the company made an earning of -S$12.34 Million, an increase over its 2024 earnings that were of -S$34.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$7.96 Million-35.48%
2025 -S$12.34 Million-64.29%
2024 -S$34.53 Million-16.9%
2023 -S$41.56 Million5.99%
2022 -S$39.21 Million-13.7%
2021 -S$45.43 Million33.25%
2020 -S$34.1 Million-172.11%
2019 S$47.27 M2352.33%
2018 S$1.92 M-94.13%
2017 S$32.85 M-154.92%
2016 -S$59.82 Million3.67%
2015 -S$57.7 Million878%
2014 -S$5.9 Million-72.64%
2013 -S$21.57 Million-33.11%
2012 -S$32.24 Million77.71%
2011 -S$18.14 Million
2003 -S$30.72 Million29.93%
2002 -S$23.64 Million36.18%
2001 -S$17.36 Million
1999 -S$14.41 Million6.04%
1998 -S$13.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.29 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.79 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.02 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.02 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.24 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.14 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.8 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$74.28 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA